196
Views
8
CrossRef citations to date
0
Altmetric
Perspectives

Time To Revise COPD Treatment Algorithm

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 2229-2234 | Published online: 27 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Konstantinos Kostikas, Katerina Dimakou, Konstantinos Gourgoulianis, Mina Gaga, Dimosthenis Papapetrou, Georgios Tsoukalas, Panagiotis Chatziapostolou, Antonios Antoniadis, Georgios Meletis, Efstathia Evangelopoulou, Panagiota Styliara, Ilektra Karypidou, Athena Gogali, Konstantinos Kalafatakis & Nikolaos Tzanakis. (2022) A Real-World Study on the Day and Night-Time Symptoms Among Greek COPD Patients Who Recently Initiated Treatment with Dual Bronchodilation: The DANICO Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2027-2041.
Read now
Arschang Valipour, Sergey Avdeev, Adam Barczyk, Valentina Bayer, Zvi Fridlender, Mariela Georgieva, Ondřej Kudela, Alexey Medvedchikov, Ramona Miron, Maria Sanzharovskaya, Virginija Šileikienė, Jurij Šorli, Marc Spielmanns & Zsuzsanna Szalai. (2021) Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 615-628.
Read now

Articles from other publishers (6)

A. G. Chuchalin, S. N. Avdeev, Z. R. Aisanov, A. S. Belevskiy, I. V. Leshchenko, S. I. OvcharenkoE. I. Shmelev. (2022) Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. PULMONOLOGIYA 32:3, pages 356-392.
Crossref
Lin Song, Juan Peng & Xuejun Guo. (2021) Exosomal lncRNA TCONS_00064356 derived from injured alveolar epithelial type II cells affects the biological characteristics of mesenchymal stem cells. Life Sciences 278, pages 119568.
Crossref
Min Li, Guang-chao Han, Yang Chen, Wen-xiu Du, Fang Liu, Yu-min Chi & Jun-feng Du. (2021) Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial. Brazilian Journal of Medical and Biological Research 54:2.
Crossref
Kazuto Matsunaga, Ichiro Kuwahira, Masayuki Hanaoka, Junpei Saito, Takahiro Tsuburai, Koichi Fukunaga, Hisako Matsumoto, Hisatoshi Sugiura & Masakazu Ichinose. (2021) An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice. Respiratory Investigation 59:1, pages 34-52.
Crossref
Kazuto Matsunaga, Misa Harada, Junki Suizu, Keiji Oishi, Maki Asami-Noyama & Tsunahiko Hirano. (2020) Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs. Journal of Clinical Medicine 9:10, pages 3078.
Crossref
Zichen Ji, Javier de Miguel-Díez, Christian Reynaldo Castro-Riera, José María Bellón-Cano, Virginia Gallo-González, Walther Iván Girón-Matute, Rodrigo Jiménez-García, Ana López-de Andrés, Virginia Moya-Álvarez, Luis Puente-Maestu & Julio Hernández-Vázquez. (2020) Differences in the Outcome of Patients with COPD according to Body Mass Index. Journal of Clinical Medicine 9:3, pages 710.
Crossref